85 related articles for article (PubMed ID: 2797225)
1. [The effect of the anthracycline derivative doxorubicin on myocardial function in children].
Sobotka-Plojhar MA; Daniëls O; Rohmer J; Veerman AJ; Lippens R; van Lier H
Ned Tijdschr Geneeskd; 1989 Jul; 133(27):1367-70. PubMed ID: 2797225
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of quantitative two-dimensional echocardiographic analysis of segmental kinesis of the left ventricle in monitoring of patients with neoplasms treated with anthracyclines].
Pisacane C; Iarussi D; Buono S; Gualtieri S; Coppolino P; Iacono A
G Ital Cardiol; 1991 Dec; 21(12):1259-67. PubMed ID: 1818000
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic evaluation of adriamycin cardiotoxicity in children.
Ramos A; Meyer RA; Korfhagen J; Wong KY; Kaplan S
Cancer Treat Rep; 1976 Sep; 60(9):1281-4. PubMed ID: 1016964
[TBL] [Abstract][Full Text] [Related]
4. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.
Lewis AB; Crouse VL; Evans W; Takahashi M; Siegel SE
Pediatrics; 1981 Jul; 68(1):67-72. PubMed ID: 6941210
[TBL] [Abstract][Full Text] [Related]
5. [Abnormal left-ventricular contraction and filling in patients receiving adriamycin for solid tumours (author's transl)].
Stein E; Hanrath P; Bleifeld W; Garbrecht M; Müllerleile U
Dtsch Med Wochenschr; 1978 Sep; 103(36):1408-12. PubMed ID: 679856
[TBL] [Abstract][Full Text] [Related]
6. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
[TBL] [Abstract][Full Text] [Related]
7. [Cardiotoxicity of doxorubicin in children].
Pilon JW; Naeff MS; Taminiau JA
Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993
[No Abstract] [Full Text] [Related]
8. [Evaluation of the cardioprotective effect of bispiperazinedione ICRF-187 (Cardioxane) in patients treated with anthracyclines--an echocardiographic study].
Elbl L; Vásová I; Chaloupka V; Hájek R; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):268-73. PubMed ID: 8693714
[TBL] [Abstract][Full Text] [Related]
9. [Early and late anthracycline-induced cardiotoxicity in childhood: non-invasive evaluation of contractility in 116 patients].
Agnoletti G; Bonazza A; Pennacchio M; Porta F; Arrighini A
G Ital Cardiol; 1995 Oct; 25(10):1295-305. PubMed ID: 8682225
[TBL] [Abstract][Full Text] [Related]
10. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
11. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
[TBL] [Abstract][Full Text] [Related]
15. [Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].
Erlaky H; Tóth K; Szabolcs J; Horváth E; Kemény V; Müller J; Csóka M; Jókúti L; Erdélyi D; Kovács G
Magy Onkol; 2006; 50(1):25-32. PubMed ID: 16617380
[TBL] [Abstract][Full Text] [Related]
16. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
[TBL] [Abstract][Full Text] [Related]
17. [Echocardiography of ischemic heart disease simulating dilated cardiomyopathy, with special reference to abnormal wall movement on the short-axis].
Fujiwara T; Tarumoto T; Kudo K; Takaya J; Murayama K; Wakiya Y; Kano T; Nishijo T; Okada R; Kitamura K
J Cardiogr; 1983 Mar; 13(1):89-101. PubMed ID: 6644120
[TBL] [Abstract][Full Text] [Related]
18. Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children.
Kremer LC; Tiel-van Buul MM; Ubbink MC; Offringa M; Ottenkamp J; Olmos RV; Voûte PA
J Clin Oncol; 1999 Apr; 17(4):1208. PubMed ID: 10561180
[TBL] [Abstract][Full Text] [Related]
19. The use of two-dimensional and Doppler echocardiography in assessing mitral regurgitation and segmental contractility disturbances in patients with dilated cardiomyopathy and ischaemic heart disease.
Mukharliamov NM; Shevliagin SA; Naumov VG; Grigoriants RA
Cor Vasa; 1986; 28(6):395-403. PubMed ID: 3829685
[TBL] [Abstract][Full Text] [Related]
20. Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review.
Azevedo VM; Santos MA; Albanesi Filho FM; Castier MB; Tura BR; Amino JG
Cardiol Young; 2007 Apr; 17(2):175-84. PubMed ID: 17244382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
